EL · Estee Lauder Companies Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.71B | $4.23B | $3.48B | $4.00B | $3.55B | $3.36B | $4.28B | $3.94B | $3.52B | $4.62B |
| Cost of Revenue | $876.00M | $994.00M | $927.00M | $957.00M | $889.00M | $928.00M | $1.15B | $1.11B | $1.07B | $1.22B |
| Gross Profit | $2.84B | $3.23B | $2.55B | $3.05B | $2.66B | $2.43B | $3.13B | $2.83B | $2.45B | $3.40B |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $2.28B | $2.63B | $2.30B | $2.58B | $2.26B | $2.30B | $2.54B | $2.28B | $2.35B | $2.63B |
| Total Operating Expenses | $2.59B | $2.83B | $2.38B | $3.63B | $2.35B | $2.55B | $2.55B | $2.30B | $2.35B | $2.85B |
| D&A | $204.00M | $207.00M | $200.00M | - | - | $208.00M | - | - | $203.00M | - |
| Operating Income | $249.00M | $401.00M | $169.00M | ($580.00M) | $306.00M | ($121.00M) | $574.00M | $531.00M | $98.00M | $556.00M |
| Interest Expense | $82.00M | $85.00M | $86.00M | $98.00M | $94.00M | $92.00M | $98.00M | $94.00M | $95.00M | $52.00M |
| Income Tax | $90.00M | $171.00M | $62.00M | ($60.00M) | $82.00M | ($24.00M) | $195.00M | $151.00M | $10.00M | $135.00M |
| Net Income | $159.00M | ($590.00M) | ($156.00M) | ($590.00M) | $159.00M | ($156.00M) | $313.00M | $330.00M | $31.00M | $394.00M |
| EPS - Basic | $0.25 | $0.45 | $0.13 | ($1.64) | $0.44 | ($0.43) | $0.87 | $0.92 | $0.09 | $1.10 |
| EPS - Diluted | $0.24 | $0.44 | $0.13 | ($1.64) | $0.44 | ($0.43) | $0.87 | $0.91 | $0.09 | $1.09 |
Balance Sheet
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.13B | $3.08B | $2.22B | $2.92B | $2.63B | $2.35B | $3.40B | $3.70B | $3.09B | $4.03B |
| Accounts Receivable | $1.75B | $1.66B | $1.88B | $1.53B | $1.79B | $1.98B | $1.73B | $1.85B | $1.91B | $1.45B |
| Inventory | $1.92B | $1.90B | $2.06B | $2.07B | $1.96B | $2.25B | $2.17B | $2.31B | $2.86B | $2.98B |
| Accounts Payable | $1.32B | $1.26B | $1.29B | $1.50B | $1.21B | $1.14B | $1.44B | $1.20B | $1.26B | $1.67B |
| Current Assets | $7.50B | $7.16B | $6.71B | $7.07B | $7.02B | $7.21B | $7.92B | $8.53B | $8.59B | $9.14B |
| Total Assets | $19.66B | $19.63B | $19.33B | $19.89B | $19.89B | $21.32B | $21.68B | $22.70B | $22.65B | $23.41B |
| Current Liabilities | $5.91B | $5.27B | $5.08B | $5.43B | $4.96B | $5.49B | $5.70B | $5.42B | $5.91B | $6.24B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $3.99B | $4.03B | $3.87B | $4.17B | $4.34B | $5.08B | $5.71B | $5.74B | $5.58B | $5.90B |
| Retained Earnings | $11.59B | $11.62B | $11.59B | $11.67B | $12.34B | $13.03B | $13.43B | $13.95B | $13.78B | $13.99B |
Cash Flow
| Line item | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($340.00M) | - | - | ($670.00M) | - | - | ($408.00M) | - |
| Investing Cash Flow | - | - | ($116.00M) | - | - | ($160.00M) | - | - | ($295.00M) | - |
| Financing Cash Flow | - | - | ($239.00M) | - | - | ($226.00M) | - | - | ($219.00M) | - |
| CapEx | - | - | $96.00M | - | - | $141.00M | - | - | $295.00M | - |
| Free Cash Flow | - | - | ($436.00M) | - | - | ($811.00M) | - | - | ($703.00M) | - |
Ratios
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q2 '25 | Q3 '25 | Q1 '25 | Q2 '24 | Q3 '24 | Q1 '24 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 76.4% | 76.5% | 73.4% | 76.1% | 75.0% | 72.4% | 73.0% | 71.9% | 69.6% | 73.6% |
| Operating margin | 6.7% | 9.5% | 4.9% | -14.5% | 8.6% | -3.6% | 13.4% | 13.5% | 2.8% | 12.0% |
| EBITDA margin | 12.2% | 14.4% | 10.6% | - | - | 2.6% | - | - | 8.6% | - |
| Net margin | 4.3% | -14.0% | -4.5% | -14.7% | 4.5% | -4.6% | 7.3% | 8.4% | 0.9% | 8.5% |
| Free cash flow margin | - | - | -12.5% | - | - | -24.1% | - | - | -20.0% | - |
| FCF / Net income | - | - | 2.79 | - | - | 5.20 | - | - | -22.68 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 61.4% | 62.1% | 66.0% | 64.6% | 63.6% | 68.4% | 59.5% | 58.0% | 66.8% | 56.9% |
| Effective tax rate | 36.1% | - | - | - | 34.0% | - | 38.4% | 31.4% | 24.4% | 25.5% |
| Return on assets | 0.8% | -3.0% | -0.8% | -3.0% | 0.8% | -0.7% | 1.4% | 1.5% | 0.1% | 1.7% |
| Return on equity | 4.0% | -14.6% | -4.0% | -14.2% | 3.7% | -3.1% | 5.5% | 5.7% | 0.6% | 6.7% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.27 | 1.36 | 1.32 | 1.30 | 1.41 | 1.32 | 1.39 | 1.58 | 1.45 | 1.46 |
| Quick ratio | 0.94 | 1.00 | 0.92 | 0.92 | 1.02 | 0.90 | 1.01 | 1.15 | 0.97 | 0.99 |
| Cash ratio | 0.53 | 0.58 | 0.44 | 0.54 | 0.53 | 0.43 | 0.60 | 0.68 | 0.52 | 0.65 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 3.0x | 4.7x | 2.0x | -5.9x | 3.3x | -1.3x | 5.9x | 5.6x | 1.0x | 10.7x |
| Equity multiplier | 4.92 | 4.87 | 5.00 | 4.77 | 4.58 | 4.19 | 3.79 | 3.95 | 4.06 | 3.97 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.19 | 0.22 | 0.18 | 0.20 | 0.18 | 0.16 | 0.20 | 0.17 | 0.16 | 0.20 |
| Inventory turnover | 0.46 | 0.52 | 0.45 | 0.46 | 0.45 | 0.41 | 0.53 | 0.48 | 0.37 | 0.41 |
| Days sales outstanding | 172d | 143d | 198d | 139d | 184d | 215d | 147d | 172d | 198d | 115d |
| Days inventory outstanding | 799d | 696d | 812d | 791d | 804d | 887d | 688d | 761d | 977d | 892d |
| Days payable outstanding | 552d | 463d | 508d | 571d | 498d | 446d | 455d | 395d | 429d | 500d |
| Cash conversion cycle | 419d | 376d | 502d | 360d | 490d | 655d | 380d | 538d | 746d | 507d |
| Valuation | ||||||||||
| P / E | 299.0x | 238.0x | 677.8x | - | 150.0x | - | 122.3x | 169.4x | 1606.1x | 180.2x |
| P / B | 6.6x | 9.5x | 8.3x | 7.0x | 5.5x | 7.1x | 6.7x | 9.7x | 9.3x | 12.0x |
| P / S | 7.1x | 9.0x | 9.2x | 7.3x | 6.7x | 10.7x | 9.0x | 14.1x | 14.8x | 15.3x |
| EV / EBITDA | 51.0x | 57.8x | 80.7x | - | - | 385.0x | - | - | 162.9x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 4.6% | 5.6% | 3.6% | -6.4% | -9.9% | -4.5% | -7.4% | 5.0% | -10.5% | -16.6% |
| Revenue CAGR (3y) | -0.3% | -2.9% | -4.0% | -10.3% | -5.8% | -8.5% | -4.1% | 0.7% | -0.4% | -0.0% |
| Revenue CAGR (5y) | -0.8% | -2.7% | -0.5% | -2.8% | 1.2% | -2.9% | 1.3% | 1.0% | -0.0% | 4.3% |
| Gross profit growth (YoY) | 6.6% | 6.2% | 5.0% | -2.5% | -6.1% | -0.6% | -8.1% | 9.3% | -15.8% | -21.2% |
| Operating income growth (YoY) | -18.6% | - | - | - | -42.4% | - | 3.2% | 78.8% | -85.2% | -60.8% |
| Net income growth (YoY) | 0.0% | 0.0% | 0.0% | - | -51.8% | - | -20.6% | 111.5% | -93.7% | -63.8% |
| EPS growth (YoY) | -45.5% | - | - | - | -51.6% | - | -20.2% | 111.6% | -93.3% | -63.3% |
| EPS CAGR (3y) | -17.7% | -26.1% | -54.2% | - | -34.0% | - | -28.4% | -9.8% | -60.1% | -10.5% |
| EPS CAGR (5y) | -28.0% | -28.6% | -38.0% | - | - | - | -10.9% | -9.6% | -41.7% | 27.0% |
| FCF growth (YoY) | - | - | 46.2% | - | - | -15.4% | - | - | 12.3% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -8.1% | -3.3% | -24.0% | -27.0% | -24.4% | -9.0% | -3.2% | -2.3% | 1.2% | 5.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-06-30.
Product / service
$100.00M totalProduct And Service Other$100.00M · 100.0%
Geographic
$14.33B totalOther Countries$6.19B · 43.2%
US$3.76B · 26.3%
CN$3.65B · 25.5%
KR$718.00M · 5.0%
Peer comparison
Same SIC group: Perfumes, Cosmetics & Other Toilet Preparations
Comparing ESTEE LAUDER COMPANIES INC against the 5 most active filers in the same SIC group.
Dividends
$1.40/share trailing 12 months · -18.1% YoY
| Ex-date | Per share |
|---|---|
| May 29, 2026 | $0.3500 |
| Feb 27, 2026 | $0.3500 |
| Nov 28, 2025 | $0.3500 |
| Sep 2, 2025 | $0.3500 |
| May 30, 2025 | $0.3500 |
| Feb 28, 2025 | $0.3500 |
| Nov 29, 2024 | $0.3500 |
| Aug 30, 2024 | $0.6600 |
| May 31, 2024 | $0.6600 |
| Feb 28, 2024 | $0.6600 |
| Nov 29, 2023 | $0.6600 |
| Aug 30, 2023 | $0.6600 |
| May 30, 2023 | $0.6600 |
| Feb 27, 2023 | $0.6600 |
| Nov 29, 2022 | $0.6600 |
| Aug 30, 2022 | $0.6000 |
| May 27, 2022 | $0.6000 |
| Feb 25, 2022 | $0.6000 |
| Nov 29, 2021 | $0.6000 |
| Aug 30, 2021 | $0.5300 |
| May 27, 2021 | $0.5300 |
| Feb 25, 2021 | $0.5300 |
| Nov 27, 2020 | $0.5300 |
| Aug 28, 2020 | $0.4800 |